Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism

Nature Chemical Biology

Volumn 4, Issue 1, 2008, Pages 33-41

  Yu, Paul B ^a,b   Hong, Charles C ^a,c   Sachidanandan, Chetana ^a   Babitt, Jodie L ^a   Deng, Donna Y ^a   Hoyng, Stefan A ^a   Lin, Herbert Y ^a   Bloch, Kenneth D ^a   Peterson, Randall T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DORSOMORPHIN; HEPCIDIN; IRON; PROTEIN; SMAD PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; EMBRYO POLARITY; GENE TARGETING; IRON BLOOD LEVEL; IRON METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ANALYSIS; TRANSCRIPTION TERMINATION; ZEBRA FISH;

DANIO RERIO;

EID: 37249010753     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.2007.54     Document Type: Article

References (50)

1. Nguyen, V.H. et al. Ventral and lateral regions of the zebrafish gastrula, including the neural crest progenitors, are established by a bmp2b/swirl pathway of genes. Dev. Biol. 199, 93-110 (1998).
2. Mullins, M.C. et al. Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes. Development 123, 81-93 (1996).
3. Furthauer, M., Thisse, B. & Thisse, C. Three different noggin genes antagonize the activity of bone morphogenetic proteins in the zebrafish embryo. Dev. Biol. 214, 181-196 (1999).
4. Mintzer, K.A. et al. Lost-a-fin encodes a type I BMP receptor, Alk8, acting maternally and zygotically in dorsoventral pattern formation. Development 128, 859-869 (2001).
5. Zhao, G.Q. Consequences of knocking out BMP signaling in the mouse. Genesis 35, 43-56 (2003).
6. Waite, K.A. & Eng, C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nat. Rev. Genet. 4, 763-773 (2003).
7. Papanikolaou, G. et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36, 77-82 (2004).
8. Shore, E.M. et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525-527 (2006).
9. Sebald, W., Nickel, J., Zhang, J.L. & Mueller, T.D. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol. Chem. 385, 697-710 (2004).
10. Nohe, A., Keating, E., Knaus, P. & Petersen, N.O. Signal transduction of bone morphogenetic protein receptors. Cell. Signal. 16, 291-299 (2004).
11. Babitt, J.L. et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38, 531-539 (2006).
12. Babitt, J.L. et al. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J. Biol. Chem. 280, 29820-29827 (2005).
13. Pigeon, C. et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819 (2001).
14. Fraenkel, P.G., Traver, D., Donovan, A., Zahrieh, D. & Zon, L.I. Ferroportin1 is required for normal iron cycling in zebrafish. J. Clin. Invest. 115, 1532-1541 (2005).
15. Nicolas, G. et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99, 4596-4601 (2002).
16. Nicolas, G. et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34, 97-101 (2003).
17. Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093 (2004).
18. Wang, R.H. et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2, 399-409 (2005).
19. Pyati, U.J., Webb, A.E. & Kimelman, D. Transgenic zebrafish reveal stage-specific roles for Bmp signaling in ventral and posterior mesoderm development. Development 132, 2333-2343 (2005).
20. Sampath, K. et al. Induction of the zebrafish ventral brain and floorplate requires cyclops/nodal signalling. Nature 395, 185-189 (1998).
21. Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 (2001).
22. Kim, E.K. et al. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J. Biol. Chem. 279, 19970-19976 (2004).
23. Yoon, M.J. et al. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55, 2562-2570 (2006).
24. Fraley, M.E. et al. Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a] pyrimidines: a new class of KDR kinase inhibitors. Bioorg. Med. Chem. Lett. 12, 2767-2770 (2002).
25. Habeck, H., Odenthal, J., Walderich, B., Maischein, H. & Schulte-Merker, S. Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr. Biol. 12, 1405-1412 (2002).
26. Little, S.C. & Mullins, M.C. Extracellular modulation of BMP activity in patterning the dorsoventral axis. Birth Defects Res. C Embryo. Today 78, 224-242 (2006).
27. Little, S.C. & Mullins, M.C. Twisted gastrulation promotes BMP signaling in zebrafish dorsal-ventral axial patterning. Development 131, 5825-5835 (2004).
28. Hammerschmidt, M. et al. Mutations affecting morphogenesis during gastrulation and tail formation in the zebrafish, Danio rerio. Development 123, 143-151 (1996).
29. Leung, A.Y. et al. Characterization of expanded intermediate cell mass in zebrafish chordin morphant embryos. Dev. Biol. 277, 235-254 (2005).
30. Yu, P.B., Beppu, H., Kawai, N., Li, E. & Bloch, K.D. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J. Biol. Chem. 280, 24443-24450 (2005).
31. Miyazono, K. & Miyazawa, K. Id: a target of BMP signaling. Sci. STKE 2002, PE40 (2002).
32. Truksa, J., Peng, H., Lee, P. & Beutler, E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc. Natl. Acad. Sci. USA 103, 10289-10293 (2006).
33. Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276 (2004).
34. Lee, P., Peng, H., Gelbart, T. & Beutler, E. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc. Natl. Acad. Sci. USA 101, 9263-9265 (2004).
35. Babitt, J.L. et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117, 1933-1939 (2007).
36. Chen, J. et al. AMPK regulation of mouse oocyte meiotic resumption in vitro. Dev. Biol. 291, 227-238 (2006).
37. Sugimoto, H. et al. BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J. 21, 256-264 (2007).
38. Feeley, B.T. et al. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone 38, 154-166 (2006).
39. Takabe, K. et al. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology 38, 1107-1115 (2003).
40. Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K. & Taga, T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J. Biol. Chem. 275, 17647-17652 (2000).
41. Qi, X. et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA 101, 6027-6032 (2004).
42. Xu, R.H. et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185-190 (2005).
43. Zhang, A.S. et al. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J. Biol. Chem. 282, 12547-12556 (2007).
44. Weiss, G. & Goodnough, L.T. Anemia of chronic disease. N. Engl. J. Med. 352, 1011-1023 (2005).
45. Westerfield, M. The Zebrafish Book 1-385 (University of Oregon Press, Eugene, Oregon, USA, 1993).
46. Weinberg, E.S. et al. Developmental regulation of zebrafish MyoD in wild-type, no tail and spadetail embryos. Development 122, 271-280 (1996).
47. Korchynskyi, O. & ten Dijke, P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891 (2002).
48. Fujii, M. et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10, 3801-3813 (1999).
49. Dennler, S. et al. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100 (1998).
50. Shimizu, A. et al. Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line. Genes Cells 3, 125-134 (1998).